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Svessel failure at 6 and 12 months, procedural success and parameters measured by
QCA (MLD, DS%, .). An OCT substudy investigates stent apposition at the initial
procedure timepoint.
Results: 220 patients were enrolled in 21 European centers. Age was 6611 years,
78% male. Diabetes was present in 30% of patients, hypertension in 76%. Medina
class 1,1,1 was found in 35% of the patients. STENTYS DES was implanted
successfully in 98% of the patients. Stenting of SB was performed in 12% of the
procedures. Revascularization was successful (TIMI 3 or 2) in 99.5% for MB, and
96.7% for SB.
Conclusions: The ongoing Open II study is the largest study assessing self-expanding
STENTYS DES in bifurcation lesions in a clinical routine setting. The primary
endpoint, MACE rate at 6 months, will be presented, and compared to landmark trials
(Nordic and BBC studies). TVF, QCA and OCT data will also be presented.
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Background: We sought to investigate the clinical impact of the use of intravascular
ultrasound (IVUS) during revascularization of patients with left main (LM) disease
with drug-eluting stents (DES). Whether the use of IVUS during the procedure adds
a clinical beneﬁt remains unclear. There is only one previous observational study with
relevant limitations supporting the value of this strategy.
Methods:We performed a patient level pooled analysis of 4 registries of patients with
LM disease treated with DES. A propensity score matching method was used to obtain
matched pairs of patients with and without IVUS guidance.
Results: A total of 1,670 patients were included and 505 patients (30.2%) underwent
PCI under IVUS guidance (IVUS group). By means of the matching method, 505
patients without the use of IVUS during PCI were selected (no-IVUS group). Survival
free of cardiac death, myocardial infarction and TLR at 3 years was 88.7% in IVUS
group and 83.6% in no-IVUS group (p¼0.04) for overall population and 90% and
80.7% respectively (p¼0.03) for the subgroups with distal LM lesions. The incidence
of deﬁnite and probable thrombosis was signiﬁcantly lower in IVUS group (0.6% vs.
2.2%; p¼0.04). Finally, IVUS resulted independent predictor for major adverse events
in overall population (HR 0.70, 95% CI 0.52 – 0.99; p¼0.04) and in the subgroup with
distal lesions (HR 0.54, 95% CI 0.34 – 0.90; p¼0.02).
Conclusions: The results of this nation-wide registries pooled analysis conﬁrms the
clinical beneﬁt derived from IVUS-guided strategy in patients with LM disease
undergoing PCI with DES, especially in distal lesions.
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Background: The very long term outcome after left main stenting (LEMANS) in
comparison wit surgical revascularization remains unknown. Therefore we report a 10
year clinical follow-up of patients enrolled in the prospective, randomized LEMANS
trial.
Methods: We randomly assigned 105 patients with unprotected left main coronary
artery stenosis (ULMCA) to percutaneous coronary intervention (PCI; 52 patients) or
coronary artery bypass grafting (CABG; 53 patients). Study design, protocol and mid-
term results were reported previously. In the current study, the mean long term follow
up was collected at 9.8  1 years after baseline procedure. Data on all cause mortalityJACC Vol 62/18/Suppl B j October 27–November 1, 2013 j TCT Abstrwere collected from all patients, whereas incidence of MACCE, which included all
cause death, myocardial infarction, stroke, repeated revascularization, from 90%.
Results: At ten years, the mortality was comparable between stenting group when
compared to surgery (23.0% vs. 28.7% p¼0.69). Similarly, the incidence of MACCE
was statistically not different to surgery (51.1 vs. 64.4%, p¼0.28), however numeri-
cally the difference was in favor of stenting. The probability of long term survival up
to 14 years was comparable between PCI and CABG (74.2 vs. 67.5%, p¼0.34
HR:1.45 95%CI: 0.67-3.13), however there was a trend toward higher MACCE-free
survival in the PCI group (34.7 vs 22.1%, p¼0.06, HR :1.71 95%CI: 0.97-2.99,
Figure).Conclusions: Left main stenting offers favorable long term outcomes up to 10 years
and constitutes an alternative therapy for CABG.
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Background: The present study aimed to compare the long term (5-year) safety and
efﬁcacy between the one-stent, two stent, and DK crush strategies, utilizing drug-
eluting stents, for unprotected left main coronary artery (ULMCA) bifurcation lesions.
Methods: Between March 2004 and April 2007, 633 consecutive patients with
ULMCA bifurcation lesions (232 in one-stent group and 401 in two-stent group) were
prospectively enrolled. The primary endpoint was the occurrence of major adverse
cardiac events (MACE), a composite of cardiac death, myocardial infarction (MI), and
target vessel revascularization (TVR), at 5-year follow-up.
Results: Patients in the two-stent group were classiﬁed as DK crush (n¼155) and the
other two-stent techniques (culotte, T stenting, Kissing stenting and classical crush,
n¼246). Forty-seven (16.8%) patients in the one-stent group crossed-over to the two-
stent group. The one-stent group was associated with increased incidence of MI
compared to the two-stent approach (10.5% vs. 5.5%, p¼0.025). The crude rate of
MACE at 5-year was 28.0% in one-stent group and 28.4% in two-stent group
(p¼0.927). DK crush was associated with a signiﬁcantly decreased 5-year MACE
compared to other two-stent approaches or the one-stent approach (DK-crush: 14.8%
vs. Other two-stent approaches: 37.0%, one-stent approach: 28.0%, p<0.001). The
main beneﬁt of DK-crush appeared to be primarily secondary to a reduction in TVR
(7.7% vs. 30.5% vs. 18.1%, p<0.001). By Cox regression analyses, the non-DK crush
two-stent technique, a high SYNTAX score (33) or New Risk Stratiﬁcation (NERS)
score (>20), and incomplete revascularization were shown to be independent
predictors of MACE at 5-year follow-up.
Conclusions: With distal left main true bifurcations, the two-stent technique
(excluding DK-crush) is an independent predictor of long term MACE. DK-crush is
associated with more favorable long-term clinical outcomes. Conﬁrmation of these
ﬁndings is required from randomized controlled trials.acts/ORAL/Bifurcation and Left Main Stenting B9
